This is an old revision of this page, as edited by Drphilharmonic (talk | contribs) at 18:11, 16 February 2011. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 18:11, 16 February 2011 by Drphilharmonic (talk | contribs)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Polymyxin B" – news · newspapers · books · scholar · JSTOR (June 2010) (Learn how and when to remove this message) |
Clinical data | |
---|---|
Routes of administration | Topical |
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.014.340 |
Chemical and physical data | |
Formula | C56H100N16O17S |
Molar mass | 1301.56 g/mol g·mol |
Polymyxin B is an antibiotic primarily used for resistant gram-negative infections. It is derived from the bacterium Bacillus polymyxa. Polymyxin B sulfate has a bactericidal action against almost all gram-negative bacilli except the Proteus group. Polymyxins bind to the cell membrane and alter its structure, making it more permeable. The resulting water uptake leads to cell death. They are cationic, basic proteins that act like detergents (surfactants). Side-effects include neurotoxicity and acute renal tubular necrosis. It is commonly used in the topical first-aid preparation Neosporin.
- Family of polypeptides with attached fatty acid; cationic detergent at physiological pH, both hydrophilic and hydrophobic properties
- Bactericidal for gram-negative; little to no effect on gram-positive, since cell wall is too thick to permit access to membrane
Mechanism of action
- Alters bacterial outer membrane permeability by binding to a negatively charged site in the lipopolysaccharide layer, which has an electrostatic attraction for the positively charged amino groups in the cyclic peptide portion (this site normally is a binding site for calcium and magnesium counter ions); the result is a destabilized outer membrane
- Fatty acid portion dissolves in hydrophobic region of cytoplasmic membrane and disrupts membrane integrity
- Leakage of cellular molecules, inhibition of cellular respiration
- Binds and inactivates endotoxin
- Relative absence of selective toxicity: nonspecific for cell membranes of any type, highly toxic
Research application
- In addition to its antibiotic function, polymix B has been used to clear endotoxin contamination in reagents.
References
- Cardoso LS, Araujo MI, Góes AM, Pacífico LG, Oliveira RR, Oliveira SC (2007). "Polymyxin B as inhibitor of LPS contamination of Schistosoma mansoni recombinant proteins in human cytokine analysis". Microb. Cell Fact. 6: 1. doi:10.1186/1475-2859-6-1. PMC 1766364. PMID 17201926.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link)
Antidiarrheals, intestinal anti-inflammatory and anti-infective agents (A07) | |
---|---|
Rehydration | |
Intestinal anti-infectives | |
Intestinal adsorbents |
|
Antipropulsives (opioids) |
|
Intestinal anti-inflammatory agents |
|
Antidiarrheal micro-organisms | |
Other antidiarrheals | |
|
Drugs used for diseases of the ear (S02) | |
---|---|
Infection | |
Corticosteroids | |
Analgesics and anesthetics |